3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
3/2
01:00 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
3/2
07:13 am
sion
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/2
07:00 am
sion
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2/27
11:30 am
sion
Assessing Sionna Therapeutics (SION) Valuation As Premium P/B Meets Cooling Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Sionna Therapeutics (SION) Valuation As Premium P/B Meets Cooling Share Price Momentum [Yahoo! Finance]
2/26
06:28 am
sion
Sionna Therapeutics (SION) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
Sionna Therapeutics (SION) was upgraded by Lifesci Capital to "strong-buy".
2/24
08:00 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $63.00 price target on the stock.
Low
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $63.00 price target on the stock.
2/24
06:03 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Medium
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
2/23
08:13 am
sion
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences [Yahoo! Finance]
Low
Report
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences [Yahoo! Finance]
2/23
08:00 am
sion
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
Low
Report
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
2/4
07:00 am
sion
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Medium
Report
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
1/14
08:04 am
sion
Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.
High
Report
Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.
1/12
04:26 am
sion
Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple [Yahoo! Finance]
Medium
Report
Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple [Yahoo! Finance]
1/7
08:02 am
sion
Sionna Therapeutics (NASDAQ:SION) had its price target raised by analysts at BTIG Research from $50.00 to $58.00. They now have a "buy" rating on the stock.
High
Report
Sionna Therapeutics (NASDAQ:SION) had its price target raised by analysts at BTIG Research from $50.00 to $58.00. They now have a "buy" rating on the stock.
1/5
07:17 am
sion
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/5
07:00 am
sion
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/3
03:13 pm
sion
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million [Yahoo! Finance]
Medium
Report
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million [Yahoo! Finance]
12/23
11:17 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $60.00 price target on the stock.
Low
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $60.00 price target on the stock.
12/13
01:11 am
sion
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at
Wall Stree
Low
Report
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at
Wall Stree